prognosis

You have access
High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
SHUNSUKE YAMAGISHI, MITSURO KANDA, TAKAHIRO SHINOZUKA, YUSUKE SATO, DAI SHIMIZU, CHIE TANAKA, SHINICHI UMEDA, HARUYOSHI TANAKA, HIDEKI TAKAMI, NORIFUMI HATTORI, MASAMICHI HAYASHI, GORO NAKAYAMA, YASUHIRO KODERA and YUKIYASU OKAMURA

Anticancer Research May 2025, 45 (5) 1997-2009; DOI: https://doi.org/10.21873/anticanres.17575
You have access
Comparative Analysis of Outcomes for Patients With Advanced Renal Cell Carcinoma: Immuno-Oncology Era Versus Tyrosine Kinase Inhibitor Era in the IMDC Favorable-risk Group
HIROKI ISHIHARA, YUKI NEMOTO, SHINSUKE MIZOGUCHI, KOICHI NISHIMURA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, JUNPEI IIZUKA, TSUNENORI KONDO and TOSHIO TAKAGI

Anticancer Research April 2025, 45 (4) 1643-1652; DOI: https://doi.org/10.21873/anticanres.17545
You have access
Male Breast Cancer: A Single Institutional Clinicopathological Profiling
SHUBHA DE SARKAR, SOIRINDHRI BANERJEE, AYDEN ISMAIL, AVENIE MAVADIA, SUNYOUNG CHOI, ARUNI GHOSE and STERGIOS BOUSSIOS

Anticancer Research March 2025, 45 (3) 1097-1104; DOI: https://doi.org/10.21873/anticanres.17497
You have access
¹⁸F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
WONSEOK WHI, HYUNJONG LEE, JUNG YONG HONG, WONSEOK KANG, YOUNG SEOK CHO, SEUNG HWAN MOON, JOON YOUNG CHOI, KYUNG-HAN LEE and SEUNG HYUP HYUN

Anticancer Research March 2025, 45 (3) 1273-1280; DOI: https://doi.org/10.21873/anticanres.17514
You have access
The Impact of Tonsillectomy on Oropharyngeal Cancer Development
SHIRRELL GLITZKY, ACHIM FRANZEN and ANNEKATRIN COORDES

Anticancer Research February 2025, 45 (2) 709-718; DOI: https://doi.org/10.21873/anticanres.17459
You have access
Prognostic Significance of Splenic Vein Invasion for Pancreatic Cancer Patients With Pancreatectomy: A Retrospective Study
RYO SAITO, HIDETAKE AMEMIYA, WATARU IZUMO, YUUKI NAKATA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA

Anticancer Research February 2025, 45 (2) 773-779; DOI: https://doi.org/10.21873/anticanres.17465
You have access
Clinical Significance of FAM83G in Breast Cancer: Association With Triple-negative Subtype and Prognosis
TAKAKO IKEDA, CHIKAKO KANNO HONDA, SASAGU KUROZUMI, TAKEHIKO YOKOBORI, AYAKA KATAYAMA, KEI MASUDA, TETSUNARI OYAMA, KYOICHI KAIRA, JUN HORIGUCHI, KEN SHIRABE and TAKAAKI FUJII

Anticancer Research November 2024, 44 (11) 4877-4883; DOI: https://doi.org/10.21873/anticanres.17313
Open Access
Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial
TAKASHI OSHIMA, TAKAKI YOSHIKAWA, YOHEI MIYAGI, SATOSHI MORITA, MICHIO YAMAMOTO, KAZUAKI TANABE, KAZUHIRO NISHIKAWA, YUICHI ITO, TAKANORI MATSUI, YUTAKA KIMURA, TORU AOYAMA, TAKASHI OGATA, HARUHIKO CHO, AKIRA TSUBURAYA and JUNICHI SAKAMOTO

Anticancer Research November 2024, 44 (11) 4951-4960; DOI: https://doi.org/10.21873/anticanres.17320
Open Access
Chemokine Profile Is Different in Normal Testis Compared to Seminoma – Especially in Tumor Infiltrating Lymphocytes
JONAS M. HÄNDELIN, HANNA-RIIKKA TEPPO, KIRSI-MARIA HAAPASAARI, RIINA K. OLLIKAINEN, JANETTE KEMPPAINEN, HANNE KUITUNEN, OUTI KUITTINEN and MILLA E.L. KUUSISTO

Anticancer Research November 2024, 44 (11) 4961-4967; DOI: https://doi.org/10.21873/anticanres.17321
Open Access
Impact of Pre-operative Lymphocyte and Albumin Combination on Adjuvant Chemotherapy and Prognosis of Gastric Cancer
TOSHIYA HIGASHI, MASAKI KIMURA, YUKI KATO, KIMIHIRO HATTORI, MANA KAWAJIRI, YUSUKE MURASE, KOYA TOCHII and HIDETOSHI MATSUNAMI

Anticancer Research November 2024, 44 (11) 5051-5058; DOI: https://doi.org/10.21873/anticanres.17329

Main menu

User menu

Search

prognosis

Pages